Analysts Have Conflicting Sentiments on These Healthcare Companies: Nanosonics Limited (OtherNNCSF) and Innovent Biologics (OtherIVBXF)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nanosonics Limited (NNCSF) and Innovent Biologics (IVBXF).

Nanosonics Limited (NNCSF)

In a report released today, John Hester from Bell Potter maintained a Hold rating on Nanosonics Limited, with a price target of A$3.20. The company’s shares closed last Wednesday at $2.30.

According to TipRanks.com, Hester is a 4-star analyst with an average return of 9.7% and a 49.0% success rate. Hester covers the Healthcare sector, focusing on stocks such as Paradigm Biopharmaceuticals, Telix Pharmaceuticals, and Pro Medicus Limited.

Nanosonics Limited has an analyst consensus of Hold, with a price target consensus of $2.40.